Bringing the fundamentals into focus…
Back to Atara Biotherapeutics, Inc.
How Atara Biotherapeutics, Inc. stacks up
ATRA · against 1,216 other Healthcare companies
Growth
58/ 100
Above the middle of the pack.
Ranked #506 of 1,217 · scores higher than 58% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 50–59, including ATRA · Click a bar to see the companies
Why growth scores 58?
Weighted metrics compared with all Healthcare companies.A mix: stronger 3-year revenue growth, but weaker revenue growth than most Healthcare peers.
- slower revenue growth over the last year: weaker than 80% of peers. Revenue growth: -6.3% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
- faster revenue growth over three years: stronger than 84% of peers. 3-year revenue growth: 23.9% vs peer median 5.8%
Metric by metric
Position: dot = ATRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ATRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -6.3% | 6.1% | 20% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 23.9% | 5.8% | 84% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ATRA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 494 | 69.1B BRL (≈$12.4B) | 59 | 57 | |
| 494 | 12.6B USD | 59 | 55 | |
| 506 | 244.2B KRW (≈$176M) | 58 | 72 | |
| 506 | 114.7B JPY (≈$780M) | 58 | 72 | |
| 506 | 82M USD | 58 | 27 | |
| 506 | 13.3B USD | 58 | 59 | |
| 506 | 50.2B USD | 58 | 49 | |
| 506 | 52.9B USD | 58 | 57 | |
| 506 | 45.6B CHF (≈$52.4B) | 58 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score